Skip to main content
. 2016 Dec 27;8(5):8447–8458. doi: 10.18632/oncotarget.14263

Table 3. Summary of meta-analysis of VEGF polymorphisms and RCC risk.

Polymorphism No. of studies No. of cases No. of controls Contrast OR (95% CI) Statistical method I2% P-value
+936C/T 6 1,445 2,337 TT vs. CC 1.38(1.11-1.72) Fixed 25.3 0.004
(rs3025039) TT vs. CT+CC 1.28(1.04-1.57) Fixed 0.0 0.019
TT+CT vs. CC 1.21(1.05-1.39) Fixed 38.7 0.010
CT vs. CC 1.17(1.00-1.37) Fixed 25.3 0.056
T vs. C 1.20(1.07-1.34) Fixed 32.0 0.001
−2578C/A 5 1,397 2,094 AA vs. CC 1.69(1.37-2.07) Fixed 0.0 0.000
(rs699947) AA vs. CA+CC 1.43(1.19-1.73) Fixed 0.0 0.000
AA+CA vs. CC 1.39(1.21-1.61) Fixed 34.8 0.000
CA vs. CC 1.31(1.12-1.52) Fixed 47.1 0.001
A vs. C 1.31(1.19-1.45) Fixed 0.0 0.000
+1612G/A 3 918 1,330 AA vs. GG 1.25(0.92-1.71) Fixed 0.0 0.159
(rs10434) AA vs. GA+GG 1.20(0.89-1.61) Fixed 0.0 0.234
AA+GA vs. GG 1.10(0.92-1.31) Fixed 0.0 0.280
GA vs. GG 1.08(0.90-1.30) Fixed 0.0 0.423
A vs. G 1.10(0.96-1.25) Fixed 0.0 0.178
−460T/C 3 677 1,299 CC vs. TT 0.88(0.38-2.01) Random 80.6 0.758
(rs833061) CC vs. TC+TT 0.93(0.47-1.84) Random 77.9 0.830
CC+TC vs. TT 0.98(0.61-1.58) Random 75.5 0.928
TC vs. TT 1.12(0.89-1.41) Fixed 31.0 0.343
C vs. T 0.92(0.58-1.46) Random 87.9 0.720
−634G/C 3 1,038 1,716 CC vs. GG 1.07(0.84-1.35) Fixed 16.4 0.581
(rs2010963) CC vs. GC+GG 1.00(0.83-1.20) Fixed 0.0 1.000
CC+GC vs. GG 1.09(0.91-1.30) Fixed 0.0 0.370
GC vs. GG 1.08(0.89-1.31) Fixed 0.0 0.429
C vs. G 1.03(0.92-1.16) Fixed 27.7 0.571
−405G/C 2 262 477 CC vs. GG 1.26(0.45-3.51) Random 68.4 0.661
(rs2010963) CC vs. GC+GG 1.11(0.51-2.41) Random 54.5 0.796
CC+GC vs. GG 1.18(0.70-2.01) Random 52.5 0.536
GC vs. GG 1.11(0.80-1.55) Fixed 13.0 0.532
C vs. G 1.14(0.72-1.79) Random 67.0 0.584
−1154G/A 2 373 516 AA vs. GG 1.19(0.77-1.84) Fixed 19.9 0.435
(rs1570360) AA vs. GA+GG 1.14(0.76-1.73) Fixed 0.0 0.528
AA+GA vs. GG 1.00(0.59-1.69) Random 58.1 0.994
GA vs. GG 1.08(0.80-1.46) Fixed 45.3 0.611
A vs. G 1.01(0.68-1.51) Random 57.1 0.948